SCHEMBL30577928

SCHEMBL30577928

CC(C)(C)OC(=O)Nc1cc2cnc(Cl)nc2n1C1CCCC1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
OPRM1 P35372 1/20 0.41
OPRD1 P41143 1/20 0.41
OGFRL1 Q5TC84 1/20 0.41
CDK4 P11802 11/20 0.40
CCND1 P24385 9/20 0.40
CDK2 P24941 3/20 0.39
STK17B O94768 1/20 0.38
STK17A Q9UEE5 1/20 0.38
CCND3 P30281 4/20 0.37
CCND2 P30279 1/20 0.37
GSK3B P49841 1/20 0.37
DYRK1A Q13627 1/20 0.37
CCNE1 P24864 2/20 0.37
CDK6 Q00534 2/20 0.37
CCNT1 O60563 2/20 0.37
CDK9 P50750 2/20 0.37
FGFR4 P22455 1/20 0.36
JAK3 P52333 1/20 0.35
BTK Q06187 1/20 0.35
KMT2A Q03164 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20425545 0.83 CDK4 (0.45) CDK4CCND1CDK2CCND3CCND2
SCHEMBL31438001 0.81 CDK4 (0.40) OPRM1OPRD1OGFRL1CDK4CCND1
SCHEMBL31372001 0.75 CDK4 (0.53) CDK4CCND1CDK2CCND3CCNE1
SCHEMBL20425411 0.75 CDK4 (0.53) CDK4CCND1CDK2CCND3CCNE1
SCHEMBL25090728 0.75 CDK4 (0.47) CDK4CCND1CDK2CCND3CCNE1
SCHEMBL25090724 0.74 CDK4 (0.47) CDK4CCND1CDK2CCND3CCNE1
SCHEMBL19711678 0.73 CDK4 (0.51) CDK4CCND1CDK2CCND3CCNE1
SCHEMBL1988950 0.73 CDK4 (0.52) CDK4CCND1CDK2CCND3CCNE1
SCHEMBL4826111 0.73 OPRM1 (0.42) OPRM1OPRD1OGFRL1CDK4CCND1
SCHEMBL15238256 0.73 CCR1 (0.37) CDK4CCND1CDK2STK17BSTK17A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-12577254-B2 Thienopyranones and furanopyranones as kinase, bromodomain, and checkpoint inhibitors Signal Rx Pharmaceuticals, Inc. 2026-03-17 US disclosed
US-11760762-B2 Thienopyranones and furanopyranones as kinase, bromodomain, and checkpoint inhibitors SIGNALRX PHARMACEUTICALS, INC. (US) 2023-09-19 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11760762-B2 Thienopyranones and furanopyranones as kinase, bromodomain, and checkpoint inhibitors CDK1, CDKN1A, CDKL1 OPRM1 4259/4885OPRD1 3520/4885OGFRL1 2954/4885
US-12577254-B2 Thienopyranones and furanopyranones as kinase, bromodomain, and checkpoint inhibitors CHEK1, CDK1, CDK3 OPRM1 2950/4885OPRD1 2419/4885OGFRL1 1415/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.